{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477220380
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = 
| source = o
| target = [[GD2]]
<!-- Clinical data -->
| tradename = 
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category = 
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[intravenous]]
<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 339169-93-6 
| ATC_prefix = none
| ATC_suffix = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| PubChem = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
<!-- Chemical data -->
| chemical_formula = 
| molecular_weight = 
}}
'''3F8''' is a murine [[IgG]]3<ref name="pmid2653466">{{cite journal |author=Kushner BH, Cheung NK |title=GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma |journal=Blood |volume=73 |issue=7 |pages=1936–41 |year=1989 |pmid=2653466 |doi= |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=2653466}}</ref> [[monoclonal antibody]] which binds to [[GD2]].<ref name="titleSloan-Kettering - Neuroblastoma: 3F8 Monoclonal Antibody Therapy Q & A">{{cite web |url=http://www.mskcc.org/mskcc/html/3215.cfm#261335 |title=Sloan-Kettering - Neuroblastoma: 3F8 Monoclonal Antibody Therapy Q & A |accessdate=2008-02-19 |format= |work=}}</ref>

It has been used in the detection and treatment of [[neuroblastoma]].<ref>{{cite journal|last1=Weinstein|first1=J. L.|title=Advances in the Diagnosis and Treatment of Neuroblastoma|journal=The Oncologist|date=1 June 2003|volume=8|issue=3|pages=278–292|doi=10.1634/theoncologist.8-3-278}}</ref> For imaging neuroblastoma, it is labelled with one of the [[radioisotope]]s [[iodine-124]] and [[iodine-131]].<ref name="pmid1902508">{{cite journal |author=Yeh SD |title=Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities |journal=J. Nucl. Med. |volume=32 |issue=5 |pages=769–76 |year=1991 |pmid=1902508 |doi= |url=http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=1902508 |name-list-format=vanc |author2=Larson SM |author3=Burch L |display-authors=3 |last4=Kushner |first4=BH |last5=Laquaglia |first5=M |last6=Finn |first6=R |last7=Cheung |first7=NK}}</ref><ref name="pmid17164597">{{cite journal |author=Dauer LT |title=Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma |journal=Health Phys |volume=92 |issue=1 |pages=33–9 |year=2007 |pmid=17164597 |doi=10.1097/01.HP.0000231583.32904.6c |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004032-200701000-00005 |name-list-format=vanc |author2=St Germain J |author3=Williamson MJ |display-authors=3 |last4=Zanzonico |first4=Pat |last5=Modak |first5=Shakeel |last6=Cheung |first6=Nai-Kong |last7=Divgi |first7=Chaitanya}}</ref>

==See also==
* [[Monoclonal antibody therapy]]

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Unnamed monoclonal antibodies]]

{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}